It is time for Congress to make it crystal clear that contract pharmacies are integral to the 340B program, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell’s blog.
Federal courts have struck down federal agency letters to six drug makers telling them their 340B contract pharmacy policies are illegal, Slafsky points out. That means the government probably will be unable to enforce the 340B contract pharmacy program for months or years, he said. More drug companies probably will announce restrictions, he predicted.
It is time for Congress to make it crystal clear that contract pharmacies are integral to the 340B program, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell’s blog.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
